248 related articles for article (PubMed ID: 21497739)
1. Liver fibrogenic cells.
Forbes SJ; Parola M
Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):207-17. PubMed ID: 21497739
[TBL] [Abstract][Full Text] [Related]
2. Hepatic myofibroblasts: a heterogeneous population of multifunctional cells in liver fibrogenesis.
Novo E; di Bonzo LV; Cannito S; Colombatto S; Parola M
Int J Biochem Cell Biol; 2009 Nov; 41(11):2089-93. PubMed ID: 19782946
[TBL] [Abstract][Full Text] [Related]
3. Hepatic myofibroblasts and fibrogenic progression of chronic liver diseases.
Novo E; Cannito S; Morello E; Paternostro C; Bocca C; Miglietta A; Parola M
Histol Histopathol; 2015 Sep; 30(9):1011-32. PubMed ID: 25896393
[TBL] [Abstract][Full Text] [Related]
4. Cellular and molecular mechanisms in liver fibrogenesis.
Novo E; Cannito S; Paternostro C; Bocca C; Miglietta A; Parola M
Arch Biochem Biophys; 2014 Apr; 548():20-37. PubMed ID: 24631571
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia, hypoxia-inducible factors and fibrogenesis in chronic liver diseases.
Cannito S; Paternostro C; Busletta C; Bocca C; Colombatto S; Miglietta A; Novo E; Parola M
Histol Histopathol; 2014 Jan; 29(1):33-44. PubMed ID: 23996844
[TBL] [Abstract][Full Text] [Related]
6. The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis.
Karin D; Koyama Y; Brenner D; Kisseleva T
Differentiation; 2016 Sep; 92(3):84-92. PubMed ID: 27591095
[TBL] [Abstract][Full Text] [Related]
7. Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells.
Novo E; Busletta C; Bonzo LV; Povero D; Paternostro C; Mareschi K; Ferrero I; David E; Bertolani C; Caligiuri A; Cannito S; Tamagno E; Compagnone A; Colombatto S; Marra F; Fagioli F; Pinzani M; Parola M
J Hepatol; 2011 May; 54(5):964-74. PubMed ID: 21145826
[TBL] [Abstract][Full Text] [Related]
8. Liver fibrosis.
Wallace K; Burt AD; Wright MC
Biochem J; 2008 Apr; 411(1):1-18. PubMed ID: 18333835
[TBL] [Abstract][Full Text] [Related]
9. Effect of human amniotic epithelial cells on pro-fibrogenic resident hepatic cells in a rat model of liver fibrosis.
Cargnoni A; Farigu S; Cotti Piccinelli E; Bonassi Signoroni P; Romele P; Vanosi G; Toschi I; Cesari V; Barros Sant'Anna L; Magatti M; Silini AR; Parolini O
J Cell Mol Med; 2018 Feb; 22(2):1202-1213. PubMed ID: 29105277
[TBL] [Abstract][Full Text] [Related]
10. Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques.
Tacke F; Weiskirchen R
Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):67-80. PubMed ID: 22149583
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition in chronic liver disease: fibrogenesis or escape from death?
Pinzani M
J Hepatol; 2011 Aug; 55(2):459-65. PubMed ID: 21320559
[TBL] [Abstract][Full Text] [Related]
12. Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario.
Parola M; Marra F; Pinzani M
Mol Aspects Med; 2008; 29(1-2):58-66. PubMed ID: 18022682
[TBL] [Abstract][Full Text] [Related]
13. ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis.
Foglia B; Cannito S; Bocca C; Parola M; Novo E
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159366
[TBL] [Abstract][Full Text] [Related]
14. Characterization of glial fibrillary acidic protein (GFAP)-expressing hepatic stellate cells and myofibroblasts in thioacetamide (TAA)-induced rat liver injury.
Tennakoon AH; Izawa T; Wijesundera KK; Golbar HM; Tanaka M; Ichikawa C; Kuwamura M; Yamate J
Exp Toxicol Pathol; 2013 Nov; 65(7-8):1159-71. PubMed ID: 23806769
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow cell transplantation is associated with fibrogenic cells apoptosis during hepatic regeneration in cholestatic rats.
Nunes de Carvalho S; da Cunha Lira D; Costa Cortez EA; de Andrade DC; Thole AA; Stumbo AC; de Carvalho L
Biochem Cell Biol; 2013 Apr; 91(2):88-94. PubMed ID: 23527637
[TBL] [Abstract][Full Text] [Related]
16. Inducible factors for cancer-associated fibroblasts in liver cancer versus myofibroblasts in inflammatory liver disease.
Okabe H; Hayashi H; Nakagawa S; Imai K; Nitta H; Arima K; Hashimoto D; Chikamoto A; Ishiko T; Beppu T; Baba H
Histol Histopathol; 2016 Feb; 31(2):141-8. PubMed ID: 26398776
[TBL] [Abstract][Full Text] [Related]
17. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis.
Iwaisako K; Brenner DA; Kisseleva T
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):65-8. PubMed ID: 22320919
[TBL] [Abstract][Full Text] [Related]
18. Mesodermal mesenchymal cells give rise to myofibroblasts, but not epithelial cells, in mouse liver injury.
Lua I; James D; Wang J; Wang KS; Asahina K
Hepatology; 2014 Jul; 60(1):311-22. PubMed ID: 24488807
[TBL] [Abstract][Full Text] [Related]
19. Cellular sources of extracellular matrix in hepatic fibrosis.
Wells RG
Clin Liver Dis; 2008 Nov; 12(4):759-68, viii. PubMed ID: 18984465
[TBL] [Abstract][Full Text] [Related]
20. The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation.
Giraudi PJ; Becerra VJ; Marin V; Chavez-Tapia NC; Tiribelli C; Rosso N
Exp Mol Pathol; 2015 Feb; 98(1):85-92. PubMed ID: 25533546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
